TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: geometric mean titer against SARS-CoV-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Composite score of coagulation activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Conceptualization of Pain
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Child Health Assessment
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in absolute recharge performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in relative recharge performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of Continuous Glucose Monitoring (CGM) system
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Delta nitrite
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient's engagement in goal-concordant reproductive health care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in hopelessness/helplessness
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: American Shoulder and Elbow Surgeons Standardized Shoulder Assessment (ASES)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Quick Disabilities of The Arm, Shoulder and Hand Questionnaire (Quick DASH)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Proportion of Double burden of malnutrition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of dietary diversity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of low frequency of morbidity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain prevention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: State-Trait anxiety score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Concentration of antihypertensive drugs in hair samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of statins in hair samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The Pittsburg Sleep Quality Index
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Number of Participants with Clinically Significant Abnormal Laboratory Values
Endpoint domain: Adverse events/effects
Primary endpoint: self-reported vision
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: self-reported independence/autonomy
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Clinically significant abnormalities in laboratory values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Child Development at age 2 years
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Tenofovir plasma concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Tenofovir-Diphosphate PBMC concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in TFV-DP colon tissue concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: plasma concentrations of mupirocin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: intranasal concentrations of mupirocin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence, nature and severity of Treatment Emergent Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Lumbar extensor endurance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lumbar repositioning tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dementia Quality of Life - DEMQOL proxy
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: IGP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MRI lesion load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change from baseline in seated systolic blood pressure for 2 mg baxdrostat
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change from baseline in seated systolic blood pressure for 1 mg baxdrostat
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Hospital antibiotic days of therapy
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Feasibility of the intervention (engagement)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Acceptability of the telehealth intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Surgical performance of the LCS Complete mobile-bearing total knee system
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Radial artery (pseudo)aneurysm formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Radial artery fistula formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Radial artery bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Serum concentration of IL6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Cough Stress Test Assessment for Stress Urinary Incontinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Urological outcomes
Primary endpoint: Change in Pelvic Organ Prolapse Quantification Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Urological outcomes
Primary endpoint: Closure of diabetic foot ulcers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in PROMIS Pediatric Psychological Distress - Short Form
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in PROMIS Pediatric Anxiety - Short Form
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in PROMIS Pediatric Depressive Symptom - Short Form
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in NIH Toolbox Perceived Stress Survey
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in PROMIS Pediatric Meaning and Purpose - Short Form
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Parent-Adolescent Communication Scale
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Change from Baseline on the Integrated Alzheimer's Disease Rating Scale (iADRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Future unscheduled healthcare utilization for asthma exacerbation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Refusal rates
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Day 14 all-cause mortality rate
Endpoint domain: Mortality/survival
Primary endpoint: Patient recovery through a change in mental state
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mother-Infant Attachment Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Boezaart scale rating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bioequivalence of test and innovator formulations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Catheter stay in place
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Body water percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Maximum plasma concentration [Cmax] of Olutasidenib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Buccolingual ridge width
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ridge height
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Academic Performance - reading
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Academic Performance - mathematics
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Platelets to lymphocytes ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Disease incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinically significant changes in Electrocardiograms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Clinically significant changes in Blood safety tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Clinically significant changes in Urinalysis safety tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Clinically significant changes in Weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Specificity of Tilmanocept Uptake Value (TUV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of Tilmanocept Uptake Value (TUV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Algorithmic Pain Labeling
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Circadian Dyssynchrony Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Delirium Motor Subtyping Scale 4 (DMSS-4)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of the eLIFT test for advanced liver fibrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Sensitivity of the Fibrometer test for advanced liver fibrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Cobb Angel
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Angle Trunk Rotation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: State-Trait Anxiety Inventory (STAI) short form
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Saliva stress biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent Change in Total Abscess and Inflammatory Nodule Count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Number of Participants with Serious AEs (SAEs), Medically Attended AEs (MAAEs), AEs Leading to Withdrawal, and AEs of Special Interest (AESIs)
Endpoint domain: Adverse events/effects
Primary endpoint: Geometric Mean Titer (GMT) of SARS-CoV-2 Antibodies Against Omicron Variant
Endpoint domain: Physiological/clinical
Primary endpoint: Seroresponse Rate Against SARS-CoV-2 Omicron Variant
Endpoint domain: Physiological/clinical
Primary endpoint: Severity of immunotherapy-related pruritus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Square Root of Geographic Atrophy Lesion Area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: interappointment interval
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Incidence density
Endpoint domain: Mortality/survival
Primary endpoint: Protection rate
Endpoint domain: Mortality/survival
Primary endpoint: Detection rate of Al18F-NOTA-LM3 on per-patient basis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SUVmax of lesions detected on Al18F-NOTA-LM3 PET/CT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in nasal endoscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in sino-nasal outcome test
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in RhinoVAS questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in immune response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Time to onset of hypoxia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Anxiety levels as measured by the Beck Anxiety Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in triglyceride index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Knowledge of age-related decline in fertility
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Propensity to discuss fertility with patients
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Knowledge and support for elective egg freezing
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Hemodynamic reaction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Duration of the scenario
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in the IRLSSG score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients enrolled into the trial
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of patients attending scan
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Acceptability of trial to eligible women
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Balance and Fall risk - Mini-Balance Evaluation Systems Test (Mini-BESTest)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Balance and Fall risk - Activities-specific Balance Confidence scale (ABC scale)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Unified Parkinson's Disease Rating Scale Part III
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in balance ability on the Burg Balance Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in number of freezing episodes on the Timed Up and Go test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number and severity of DLTs
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of AE and SAE
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with physical examinations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Pediatric Evaluation of Disability Inventory - Computer Adaptive Test (PEDI-CAT)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in Family Empowerment Scale (FES)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Metabolome profile in tears
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Metabolome profile in intra-cellular contents
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lipidome profile in tears
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lipidome profile in intra-cellular contents
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes in cognition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: occurrence of Treatment-Emergent Adverse Events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Vascular changes in superior mesenteric and anterior cerebral arteries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: desaturation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of Remote Ischemic Conditioning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Social-Emotional Regulation Skills
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Sensory Processing Abilities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resilience measured by Connor-Davidson Resilience Scale (CD-RISC)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Sleep quality measured by Pittsburgh Sleep Quality Index (PSQI)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Prevalence of early-staged lung cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Health Literacy in Cancer Screening
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cortisol (stress hormones)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Percent attendance
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Urgency Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Narcotic Usage
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Time-to-activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of Cytomegalovirus (CMV) reactivation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Cytomegalovirus (CMV) viral load kinetics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Maternal childbirth experience
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Maternal experience with induction of labor
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of participants with asthma exacerbations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Cumulative asthma exacerbation days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Amount of fluid dialyzed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Proportion of Eyes With LogMAR Visual Acuity Less Than 0.176
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants Prescribed a Statin (population level)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of Participants Prescribed a Statin (office-visit level)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Rate of curative resection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in mean symptom severity of gastrointestinal symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Duration of audio-recorded decision-making discussions
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Incidence and activity of CE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraocular Pressure Measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glucose in mg/dl
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Urinary Pain Severity Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Reduction in Callous-Unemotional traits
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in Conduct disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in Conduct Problems
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in Emotion regulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in Emotion recognition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global perception of change after treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of Acute Procedural Success
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Adverse Drug Reaction (ADR) phenotype
Endpoint domain: Adverse events/effects
Primary endpoint: Stress-induced neural activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of patients with hyperpigmentation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Number of images correctly identified as per their original classification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nutritional improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Trunk impairment scale (TIS) for Stroke Patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Persistence of tocilizumab treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the pain intensity time curve (AUC0-48)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Infectious diseases screening uptake
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: acute voiding dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Recruitment efficacy
Endpoint domain: Resource use
Endpoint subdomain: Other resource use